ALX-1

N/A

Report date: 2026/05/13 20:02:10
NMEFirst In Class

Base Information

Drug NameALX-1
Drug Alias Namenitric oxide prodrug (Vast Therapeutics)ALX-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide donors
TargetsUpdating
Therapy Area/IndicationsMultidrug-Resistant InfectionBronchiectasisRespiratory Tract Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVast Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVast Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMultidrug-Resistant InfectionBronchiectasisRespiratory Tract Diseases +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A